STAG2 and myelodysplastic syndrome: Mutated STAG2 (cohesin complex): Mutations in the cohesin subunit SA-2 (STAG2) define AML with myelodysplasia-related gene mutations, irrespective of prior MDS [1], and are considered a marker of poor prognosis.